Journey Medical Corp's ability to collect accounts receivable sequentially worsen to 2.5, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Journey Medical's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 146 days, from 125 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 475 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2906 to 3112.

What is Receivable Turnover Ratio?
What is Journey Medical Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DERM Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	131.69 %	38.65 %	191.11 %	68.52 %	49.49 %
Y / Y Revenue Change	23.33 %	21.48 %	18.05 %	20.52 %	1.04 %
Receivable Turnover Ratio (TTM)	2.5	2.93	3.04	3.84	4.13
DERM's Total Ranking	# 3112	# 2906	# 1428	# 1089	#
Accounts Receivable average collection period days	146	125	120	95	88
Seq. Receivable Change	45.03 %	-16.09 %	65.62 %	14.95 %	-13.21 %
Seq. Revenue Change	15.97 %	-0.73 %	-8.8 %	17.47 %	14.23 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 152
Healthcare Sector	# 476
Overall Market	# 3112

Receivable Turnover Ratio Statistics
High	Average	Low
1013.04	46.11	0.82
(Jun 30 2018)		(Mar 31 2022)

DERM Company Profile • Back to DERM Efficiency Comparisons • Compare DERM Receivables Turnover Ratio to its Competitors

Financial Statements
Journey Medical's Accounts Receivable	$ 36 Millions	Visit DERM's Balance sheet
Journey Medical's Sales TTM	$ 68 Millions	Visit DERM's Income Statement
Sources of DERM's Revenues		Visit DERM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DERM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DERM's Growth Rates	DERM's Roa	DERM's Inventory Turnover Ratio	DERM's Dividend Comparisons
DERM's Profitability Ratios	DERM's Roi	DERM's Asset Turnover Ratio	DERM's Dividend Growth
DERM's Valuation Ratios	DERM's Roe	DERM's Financial Strength Ratios	DERM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Bausch and Lomb Corp	4.65	$ 5,324.000 Millions	$ 1,144.000 Millions
Davita Inc	4.64	$ 14,009.646 Millions	$ 3,018.719 Millions
Orasure Technologies Inc	4.62	$ 111.978 Millions	$ 24.227 Millions
Kura Oncology Inc	4.60	$ 77.225 Millions	$ 16.784 Millions
Yunhong Green Cti Ltd	4.58	$ 20.662 Millions	$ 4.513 Millions
Bionexus Gene Lab Corp	4.48	$ 3.127 Millions	$ 0.697 Millions
Bellevue Life Sciences Acquisition Corp	4.47	$ 1.809 Millions	$ 0.404 Millions
Vaso Corporation	4.44	$ 80.220 Millions	$ 18.048 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	4.40	$ 25.185 Millions	$ 5.729 Millions
Neurocrine Biosciences Inc	4.40	$ 3,373.900 Millions	$ 767.475 Millions
Organon and Co	4.31	$ 6,139.000 Millions	$ 1,422.750 Millions
Alkermes Plc	4.30	$ 1,667.652 Millions	$ 388.132 Millions
Glaukos Corp	4.29	$ 500.031 Millions	$ 116.471 Millions
Regenxbio Inc	4.13	$ 174.482 Millions	$ 42.238 Millions
Inspiremd Inc	4.12	$ 10.502 Millions	$ 2.550 Millions
Medinotec Inc	4.07	$ 10.247 Millions	$ 2.519 Millions
Pelthos Therapeutics Inc	4.03	$ 43.304 Millions	$ 10.757 Millions
Gyre Therapeutics Inc	4.02	$ 119.383 Millions	$ 29.697 Millions

Date modified: 2026-09-04T04:02:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.